SLDB CIK: 1707502

Solid Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−77.8
FY22:
−98.0
FY23:
−94.2
FY24:
−100
FY25:
−156
Change from FY21 to FY25
millions USD
FY21:
−91.1
FY22:
59.2
FY23:
9.69
FY24:
−16.1
FY25:
−58.5
Change from FY21 to FY25
millions USD
FY21:
135
FY22:
74.8
FY23:
3.12
FY24:
122
FY25:
194
millions USD
FY21:
−33.9
FY22:
36.0
FY23:
−81.4
FY24:
6.34
FY25:
−20.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−79.0
FY22:
−101
FY23:
−95.7
FY24:
−101
FY25:
−157

All amounts in millions USD Data source:SEC EDGAR